Skip to main content

MoneyWorks4Me

FDC receives EIR for Aurangabad facility

31 Oct 2018 Evaluate

FDC has received an Establishment Inspection Report (EIR) for its manufacturing facility located at B-8, MIDC Industrial Area, Waluj, Aurangabad, Maharashtra, which was inspected from August 10, 2018 to August 16, 2018 by US Food and Drug Administration (USFDA).

The facility is considered to be acceptable with regards to current Good Manufacturing Practices (GMPs) and the inspection stands closed.

FDC is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..